Our results indicate that HPWE treatment attenuates the expression of PLIN1 and ATF-3, thereby supporting the hypothesis that HPWE exerts anti-obesity effects in vitro. This evidence concerns the gene ATF3 and obesity due to melanocortin 4 receptor deficiency.